Salo Ooft

1.7k total citations · 1 hit paper
5 papers, 605 citations indexed

About

Salo Ooft is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Salo Ooft has authored 5 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Cancer Research and 1 paper in Molecular Biology. Recurrent topics in Salo Ooft's work include Cancer Genomics and Diagnostics (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Cells and Metastasis (2 papers). Salo Ooft is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Cells and Metastasis (2 papers). Salo Ooft collaborates with scholars based in Netherlands, Brazil and Spain. Salo Ooft's co-authors include Emile E. Voest, Krijn K. Dijkstra, Fleur Weeber, Chelsea McLean, Joris van de Haar, Louisa R. Hoes, Evert Bosdriesz, Fried Zwartkruis, Luuk J. Schipper and Jan N.M. IJzermans and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Salo Ooft

5 papers receiving 598 citations

Hit Papers

Tumor Organoids as a Pre-clinical Cancer Model for Drug D... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salo Ooft Netherlands 4 386 201 195 186 83 5 605
Jenny E. Chu Canada 7 444 1.2× 289 1.4× 67 0.3× 184 1.0× 81 1.0× 15 619
Natalia Bednarz‐Knoll Poland 16 481 1.2× 280 1.4× 117 0.6× 344 1.8× 209 2.5× 28 800
Djamila Ouaret United Kingdom 10 281 0.7× 278 1.4× 59 0.3× 147 0.8× 142 1.7× 15 583
Kyle Chang United States 13 432 1.1× 353 1.8× 138 0.7× 244 1.3× 82 1.0× 27 825
Shannon Decker United States 2 327 0.8× 243 1.2× 103 0.5× 156 0.8× 79 1.0× 3 662
Laura Austin United States 6 532 1.4× 296 1.5× 110 0.6× 418 2.2× 136 1.6× 11 740
He Dou China 5 218 0.6× 302 1.5× 99 0.5× 207 1.1× 99 1.2× 10 646
Daniel R. Zweitzig United States 8 283 0.7× 360 1.8× 71 0.4× 194 1.0× 103 1.2× 15 636
Nina G. Steele United States 13 472 1.2× 276 1.4× 141 0.7× 176 0.9× 114 1.4× 28 811
Blake W. Goodman United States 3 385 1.0× 328 1.6× 71 0.4× 228 1.2× 52 0.6× 3 588

Countries citing papers authored by Salo Ooft

Since Specialization
Citations

This map shows the geographic impact of Salo Ooft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salo Ooft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salo Ooft more than expected).

Fields of papers citing papers by Salo Ooft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salo Ooft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salo Ooft. The network helps show where Salo Ooft may publish in the future.

Co-authorship network of co-authors of Salo Ooft

This figure shows the co-authorship network connecting the top 25 collaborators of Salo Ooft. A scholar is included among the top collaborators of Salo Ooft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salo Ooft. Salo Ooft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Haar, Joris van de, Salo Ooft, Louisa R. Hoes, et al.. (2022). Codon-specific KRAS mutations predict overall survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.. Journal of Clinical Oncology. 40(16_suppl). 3593–3593. 1 indexed citations
2.
Ooft, Salo, Fleur Weeber, Luuk J. Schipper, et al.. (2021). Prospective experimental treatment of colorectal cancer patients based on organoid drug responses. ESMO Open. 6(3). 100103–100103. 89 indexed citations
3.
Nadal, Ernest, Evert Bosdriesz, Salo Ooft, et al.. (2020). Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours. Nature Communications. 11(1). 3157–3157. 67 indexed citations
4.
Kloosterman, Wigard P., Robert R.J. Coebergh van den Braak, Mark Pieterse, et al.. (2017). A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer. Cancer Research. 77(14). 3814–3822. 67 indexed citations
5.
Weeber, Fleur, Salo Ooft, Krijn K. Dijkstra, & Emile E. Voest. (2017). Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery. Cell chemical biology. 24(9). 1092–1100. 381 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026